AMN Healthcare Files 8-K for Regulation FD Disclosure

TL;DR

AMN Healthcare just dropped an 8-K, likely with material info. Watch this space.

AI Summary

On September 22, 2025, AMN Healthcare Services, Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure, meaning it contains material non-public information that is being disclosed to the public. No specific financial transactions or events are detailed in the provided text, but the filing itself is the key event.

Why It Matters

This filing signals that AMN Healthcare Services, Inc. is making a public disclosure of material information, which could impact investor understanding of the company's current status or future outlook.

Risk Assessment

Risk Level: low — The filing is a standard disclosure document (8-K) and does not inherently indicate financial distress or significant negative events based on the provided text.

Key Players & Entities

• AMN HEALTHCARE SERVICES, INC. (company) — Registrant
• September 22, 2025 (date) — Date of report
• Regulation FD Disclosure (disclosure) — Item Information

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share AMN NYSE Indicate by ch
• $750.0 million — i) reduce the size of the facility from $750.0 million to $450.0 million, (iii) remove the ten
• $450.0 m — of the facility from $750.0 million to $450.0 million, (iii) remove the ten basis point

Filing Documents

• eh250681303_8k.htm (8-K) — 25KB
• 0000950142-25-002481.txt ( ) — 186KB
• amn-20250922.xsd (EX-101.SCH) — 3KB
• amn-20250922_lab.xml (EX-101.LAB) — 33KB
• amn-20250922_pre.xml (EX-101.PRE) — 22KB
• eh250681303_8k_htm.xml (XML) — 4KB

01

Item 7.01. Regulation FD Disclosure. AMN Healthcare Services, Inc. (the "Company") and AMN Healthcare, Inc., a wholly owned subsidiary of the Company (the "Borrower") intend to enter into an amendment (the "Fifth Amendment") to the existing Credit Agreement (as amended, the "Credit Agreement"), dated as of February 9, 2018, by and among the Company, the Borrower, certain subsidiaries of the Company as guarantors, the several lenders party thereto from time to time (the "Lenders") and Truist Bank, as administrative agent. Pursuant to the Fifth Amendment, the Company's existing secured revolving credit facility will be amended to (i) mature in October 2030 (from February 2028), (ii) reduce the size of the facility from $750.0 million to $450.0 million, (iii) remove the ten basis point credit spread adjustment with respect to the Adjusted Term SOFR Adjustment (as defined in the Credit Agreement), (iv) revise the Consolidated Net Leverage Ratio (as calculated in accordance with the Credit Agreement) to be no greater than 5.25 to 1.00, and (v) with respect to interest rate calculations, add a new pricing tier for Net Leverage Ratio >=4.25x of 2.00% for SOFR loans, 1.00% for Base Rate Loans, 2.00% for Letter of Credit Fee and 0.35% for the Unused Fee (each as defined in the Credit Agreement). The payment and interest terms and covenants under the Existing Credit Agreement will otherwise remain unchanged. The Administrative Agent has informed the Borrower that it has received sufficient consents from its lenders to enter into the Fifth Amendment, subject to the execution of final documentation, which is expected to occur in the fourth quarter of 2025. The information in this Item 2.02 and Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under t

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMN Healthcare Services, Inc. Date: September 22, 2025 By: /s/ Brian Scott Name: Brian Scott Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR